Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

The Athira team. (Athira Photo)

Athira Pharma is aiming to go public.

The Seattle biotech filed initial IPO paperwork Wednesday, a surprising move that would give the company additional capital to develop its therapies for brain diseases.

Founded in 2011, Athira is in late-stage development for its

This post was originally published on this site


Check out